Key points are not available for this paper at this time.
Accounting for 5 to 7% of all lymphomas, mantle-cell lymphoma has historically been associated with a poor outcome, but survival is improving. The epidemiology, pathology, pathophysiology, diagnosis, and treatment of mantle-cell lymphoma are described.
Armitage et al. (Wed,) studied this question.